Litecoin vs Enzyme — how do they compare? Litecoin trades at Rp796,993 (market cap Rp61,87T, Rp2,32T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Litecoin is far larger — about 461268.9× Enzyme's market cap, and Litecoin's supply is capped (77,5M / 84M LTC (93%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Litecoin for 76 Days and Enzyme for 29 Days on average.
| LTC | MLN | |
|---|---|---|
Market Cap | Rp61,87T | Rp134,13M |
Volume (24h) | Rp2,32T | Rp104,56M |
Circulating Supply | 77,5M / 84M LTC (93%) | 3,3M MLN |
Typical Hold Time | 76 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
Litecoin is trading at Rp798,808 with a market cap of Rp62 trillion, showing a bearish technical signal as it hovers near key support levels. The asset faces selling pressure from moving averages, though oscillators are neutral. On-chain metrics indicate 93% of max supply is circulating, with an average hold time of 76 days, suggesting moderate investor retention amid current market conditions.
Overall outlook remains cautious due to bearish technicals and neutral fundamentals, with opportunities in potential rebounds from support. Key risks include high volatility, regulatory uncertainty in crypto markets, and limited recent ecosystem developments impacting momentum.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Litecoin was launched in late 2011 by former Google and Coinbase engineer, Charlie Lee. It was designed to provide fast, secure and low-cost payments by leveraging the unique properties of blockchain technology. It also has a maximum supply of 84 million litecoins.
Read more on LTC →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →